News / 

FDA Panel Recommends Banning Asthma Inhaler

FDA Panel Recommends Banning Asthma Inhaler


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

(KSL News) -- Asthma sufferers may soon lose some options.

An official at the company that makes Primatene Mist says it's among the inhalers a Food and Drug Administration advisory panel recommended for a ban today.

The panel says the inhalers contain chemicals that harm the ozone layer.

An estimated three million Americans use Primatene Mist.

Most recent News stories

KSL.com Beyond Series

KSL Weather Forecast

KSL Weather Forecast
Play button